Xtant Medical Holdings (XTNT) Research & Development (2013 - 2025)
Xtant Medical Holdings (XTNT) reported Research & Development of $634000.0 for Q3 2025, down 9.56% year-over-year from $701000.0 in Q3 2024, and up 12.01% quarter-over-quarter from $566000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Research & Development (2013 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 13 years of Research & Development data on file, last reported at $634000.0 in Q3 2025.
- Research & Development for Q3 2025 came in at $634000.0, down 9.56% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.2 million (down 8.11% YoY), and the FY2024 annual result was $2.4 million, up 78.52% from the prior year.
- Research & Development grew to $634000.0 in Q3 2025 per XTNT's latest filing, from $566000.0 in the prior quarter.
- Over five years, Research & Development peaked at $701000.0 in Q3 2024 and troughed at $151000.0 in Q4 2021.
- A 5-year average of $376315.8 and a median of $262000.0 in 2021 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2024: Research & Development slipped 25.31% in 2023, then soared 253.33% in 2024.
- A 5-year view of Research & Development shows it stood at $151000.0 in 2021, then jumped by 53.64% to $232000.0 in 2022, then surged by 112.07% to $492000.0 in 2023, then grew by 6.1% to $522000.0 in 2024, then grew by 21.46% to $634000.0 in 2025.
- Business Quant data shows XTNT's Research & Development at $634000.0 in Q3 2025, $566000.0 in Q2 2025, and $443000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 263.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 345.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 566,000.00 |
| Mar 31, 2025 | 443,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 701,000.00 |
| Jun 30, 2024 | 636,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 492,000.00 |
| Sep 30, 2023 | 490,000.00 |
| Jun 30, 2023 | 180,000.00 |
| Mar 31, 2023 | 174,000.00 |
| Dec 31, 2022 | 232,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 213,000.00 |
| Dec 31, 2021 | 151,000.00 |
| Sep 30, 2021 | 262,000.00 |
| Jun 30, 2021 | 243,000.00 |
| Mar 31, 2021 | 214,000.00 |
| Dec 31, 2020 | 128,000.00 |